N/A N=16 Other

MyPhonak App Junior Pediatric Usability and Benefit Investigation

Hearing Loss

Bottom Line

View on ClinicalTrials.gov: NCT05055453 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Jun 2024

Primary outcome: Primary: dB SNR (Decibel Signal to Noise Ratio) Score Using the OLSA (Oldenburg Sentence Test) Speech in Noise Test — -1.33; -2.83; 0.08 dB — p=<0.001

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: MyPhonak Junior App (Device); Phonak Sky hearing aid (Device)
Age: Pediatric · 7+ yrs
Sex: All
Sponsor: Sonova AG
Primary completion: Dec 2022

Outcome Measures

Outcome	Result	p-value
PRIMARY dB SNR (Decibel Signal to Noise Ratio) Score Using the OLSA (Oldenburg Sentence Test) Speech in Noise Test	-1.33; -2.83; 0.08	<0.001 sig
SECONDARY Assessment of Hearing Situations in Children's Every Day Lives Questionnaire	2.61; 1.88; 2.42; 1.55	<0.001 sig

Summary

Participants age 8-17 with bilateral hearing loss will be fit with Phonak BTE (Behind-The-Ear) hearing aids and given access to the myPhonak Junior hearing app. The participants will use the app to adjust the hearing aid microphone and noise reduction settings.

Eligibility Criteria

Inclusion Criteria

Children and adolescents between the ages of 7 and 17 years old.
bilateral mild to severe hearing loss
experienced hearing aid users for 6+ months

Exclusion Criteria

any additional disabilities to the hearing impairment
inability to complete the study procedures

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05055453). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.